ici 118551 and dopexamine

ici 118551 has been researched along with dopexamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muir, WW1
Bass, AS1
Böhm, M; Erdmann, E; Kemkes, B; Klövekorn, WP; Pieske, B; Schnabel, P; Schwinger, R1
Farmer, JB; Hall, JC; Simpson, WT; Smith, GW1
Amenta, F; Cavallotti, C; Napoleone, P; Ricci, A1
Abdul-Hussein, N; Chang, DH; Einstein, R; Matthews, R; Richardson, DP; Wong, TW1
Gebhard, MM; Häcker, A; Martin, E; Schmidt, H; Schmidt, W1

Other Studies

7 other study(ies) available for ici 118551 and dopexamine

ArticleYear
Inotropic mechanisms of dopexamine hydrochloride in horses.
    American journal of veterinary research, 1992, Volume: 53, Issue:8

    Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiac Output; Dopamine; Dopamine Antagonists; Heart Rate; Hemodynamics; Horses; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Vascular Resistance

1992
Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:2

    Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Blood Pressure; Dogs; Dopamine; Drug Interactions; Glomerular Filtration Rate; Kidney; Male; Propanolamines; Receptors, Dopamine; Sodium

1990
Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic Agonists; Adrenergic beta-Antagonists; Binding, Competitive; Dopamine; Female; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Propanolamines; Receptors, Adrenergic, beta

1989
The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    The Journal of pharmacy and pharmacology, 1987, Volume: 39, Issue:8

    Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Dogs; Dopamine; Female; Ganglionic Blockers; Hemodynamics; Isoproterenol; Male; Propanolamines; Receptors, Adrenergic, beta; Receptors, Dopamine

1987
Dopexamine hydrochloride in the human kidney: localization, receptor binding and effect on 3'-5'-cyclic adenosine monophosphate generation.
    Nephron, 1993, Volume: 65, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Autoradiography; Benzazepines; Binding Sites; Binding, Competitive; Cyclic AMP; Dopamine; Dopamine Agents; Humans; In Vitro Techniques; Kidney; Middle Aged; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2

1993
Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Anesthesia; Animals; Blood Pressure; Dogs; Dopamine; Dose-Response Relationship, Drug; Heart Rate; Infusions, Intravenous; Myocardial Contraction; Pressoreceptors; Propanolamines; Raclopride; Reproducibility of Results; Salicylamides; Stimulation, Chemical

1994
Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors.
    Critical care medicine, 1998, Volume: 26, Issue:10

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bacteremia; Capillary Permeability; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Escherichia coli Infections; Leukocytes; Male; Mesentery; Microcirculation; Propanolamines; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasodilator Agents

1998